Nuwellis Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
NUWE
- Investments
-
3
- Share Price
-
$4.90
- (As of Friday Closing)
Nuwellis General Information
Description
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Contact Information
Website
www.nuwellis.comCorporate Office
- 12988 Valley View Road
- Eden Prairie, MN 55344
- United States
Corporate Office
- 12988 Valley View Road
- Eden Prairie, MN 55344
- United States
Nuwellis Timeline
Nuwellis Stock Performance
As of 13-Nov-2026, Nuwellis’s stock price is $4.90. Its current market cap is $2.65M with 541K shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.90 | $5.03 | $2.52 - $1.56K | $2.65M | 541K | 820K | -$997.02 |
Nuwellis Financials Summary
As of 30-Jun-2026, Nuwellis has a trailing 12-month revenue of $9M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | (699) | 181 | 3,541 | (2,227) |
| Revenue | 9,013 | 8,270 | 8,740 | 8,864 |
| EBITDA | (4,877) | (6,546) | (5,243) | (16,356) |
| Net Income | (11,323) | (17,521) | (11,165) | (20,209) |
| Total Assets | 9,126 | 6,118 | 9,864 | 9,770 |
| Total Debt | 200 | 328 | 545 | 760 |
Nuwellis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nuwellis Comparisons
Industry
Financing
Details
Nuwellis Competitors (4)
One of Nuwellis’s 4 competitors is Sequana Medical, a Formerly VC-backed company based in Sint-Denijs-Westrem, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sequana Medical | Formerly VC-backed | Sint-Denijs-Westrem, Belgium | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Paragate Medical | Venture Capital-Backed | Haifa, Israel | ||||
| Baxter International | Corporation | Deerfield, IL |
Nuwellis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nuwellis Patents
Nuwellis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11813390-B1 | Extracorporeal blood filtering machine and methods | Active | 20-Feb-2023 | ||
| US-11865302-B1 | Extracorporeal blood filtering machine and methods | Active | 20-Feb-2023 | ||
| US-11986584-B1 | Extracorporeal blood filtering machine and methods | Active | 20-Feb-2023 | ||
| US-11998673-B1 | Extracorporeal blood filtering machine and methods | Active | 20-Feb-2023 | ||
| US-12280007-B2 | Extracorporeal blood filtering machine and methods | Active | 20-Feb-2023 | A61M1/154 |
Nuwellis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nuwellis Investments & Acquisitions (3)
Nuwellis’s most recent deal was a Merger/Acquisition with RenalSense for . The deal was made on 17-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RenalSense | 17-Mar-2026 | Merger/Acquisition | Monitoring Equipment | ||
| Vasamed (AcQtrac System technology) | 05-Sep-2018 | Corporate Asset Purchase | Buildings and Property | ||
| Baxter International (Aquadex product line) | 08-Aug-2016 | Corporate Asset Purchase | Buildings and Property |
Nuwellis ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
37.05 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Nuwellis FAQs
-
When was Nuwellis founded?
Nuwellis was founded in 1999.
-
Where is Nuwellis headquartered?
Nuwellis is headquartered in Eden Prairie, MN.
-
What is the size of Nuwellis?
Nuwellis has 38 total employees.
-
What industry is Nuwellis in?
Nuwellis’s primary industry is Therapeutic Devices.
-
Is Nuwellis a private or public company?
Nuwellis is a Public company.
-
What is Nuwellis’s stock symbol?
The ticker symbol for Nuwellis is NUWE.
-
What is the current stock price of Nuwellis?
As of 13-Nov-2026 the stock price of Nuwellis is $4.90.
-
What is the current market cap of Nuwellis?
The current market capitalization of Nuwellis is $2.65M.
-
What is Nuwellis’s current revenue?
The trailing twelve month revenue for Nuwellis is $9M.
-
Who are Nuwellis’s competitors?
Sequana Medical, Medtronic, Paragate Medical, and Baxter International are competitors of Nuwellis.
-
What is Nuwellis’s annual earnings per share (EPS)?
Nuwellis’s EPS for 12 months was -$997.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
